BTIG to Host Ophthalmology Day on November 29, 2022

BTIG announced today that Ophthalmology Day at BTIG will take place on Tuesday, November 29, 2022. The virtual, one-day event will include thematic panel discussions, one-on-one meetings and company presentations. The event will be hosted by:

• Ryan Zimmerman, BTIG Medical Technology Analyst
• Tom Shrader, PhD, CFA, BTIG Biotechnology Analyst
• Yun Zhong, PhD, BTIG Biotechnology Analyst
• Julian Harrison, BTIG Biotechnology Analyst
• Bhavin Patel, PharmD, BTIG Healthcare Strategy and Franchise Sales Specialist
• Kenny Storch, BTIG Healthcare Strategy and Franchise Sales Specialist

“BTIG’s focus on Ophthalmology continues to expand across devices, diagnostics, digital health, and therapeutics as we see significant growth opportunities for companies taking on the largest challenges in the space,” commented Mr. Zimmerman. “The BTIG Ophthalmology Day will provide a forum for BTIG’s institutional investor clients to explore emerging innovation in ophthalmology and take a look at what’s on the horizon.”

More than 30 public and private medical technology and biotechnology companies will be participating in BTIG’s event this month. Panel discussion topics will include exploring the latest developments and trends within ophthalmic medical technologies and therapeutics.

For more information about the event, email info@btig.com. Please note that participants must be pre-registered to attend. To access BTIG insights, contact a firm representative or log in to www.btigresearch.com.

Ophthalmology Day at BTIG is being produced by BTIG’s Corporate Access program which hosts client events across the consumer, energy and infrastructure, financials, healthcare, real estate as well as technology, media, and telecommunications sectors.

About BTIG

BTIG is a global financial services firm specializing in institutional trading, investment banking, research and related brokerage services. With an extensive global footprint and more than 750 employees, BTIG, LLC and its affiliates operate out of 23 cities throughout the U.S., and in Europe, Asia and Australia. BTIG offers execution, expertise and insights for equities, equity derivatives, ETFs and fixed income, currency and commodities (futures, commodities, foreign exchange, interest rates, credit, and convertible and preferred securities). The firm’s core capabilities include global execution, portfolio, electronic and outsource trading, investment banking, prime brokerage, capital introduction, corporate access, research and strategy, commission management and more.

Disclaimer: https://www.btig.com/disclaimer. To learn more about BTIG, visit www.btig.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221123005142/en/